Complete Resolution of Retroperitoneal Lymphangioma with a Single Trial of OK-432 in an Infant.
نویسندگان
چکیده
Retroperitoneal lymphangioma is extremely rare. Although these neoplasms are benign, they can grow progressively with subsequent compression and infiltration of the adjacent structures. Surgical excision is demanding when the lesion surrounds vital structures and it is generally fraught with a high recurrence and morbidity rate. We report the case of a huge retroperitoneal lymphangioma in a newborn treated successfully with intracystic injection of OK-432.
منابع مشابه
Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial.
OBJECTIVE To describe and to determine the robustness of our study evaluating the efficacy of OK-432 (Picibanil) as a therapeutic modality for lymphangiomas. DESIGN AND SETTING Prospective, randomized trial and parallel-case series at 13 US tertiary care referral centers. SUBJECTS Thirty patients diagnosed as having lymphangioma. Ages in 25 ranged from 6 months to 18 years. Twenty-nine had ...
متن کاملCystic hygroma of arm treated with OK-432: A case report
Introduction: Cystic hygroma is a type of lymphangioma and is located most frequently in the head and neck region, followed by axilla, superior mediastinum, and mesentery and retroperitoneal. Its occurrence in upper extremity is rarely reported in literature. Case Report: We report a newborn baby with Down’s syndrome presented with cystic hygroma in his left arm and forearm. Patient was treated...
متن کاملChronic Low Back Pain due to Retroperitoneal Cystic Lymphangioma
Abdominal cystic lymphangioma is a rare benign neoplasm. Less than 1% of lymphangiomas is in the retroperitoneum. Lymphangioma is mostly asymptomatic. Chronic symptoms were reported in retroperitoneal type more than others. Acute symptoms due to complications like infection, cyst rupture or hemorrhage may occur. We report an 18-years-old girl with low back pain from 6 months ago with huge pel...
متن کاملSclerosing treatment of lymphangiomas with OK-432.
Over a period of seven years, 15 patients (aged from birth to 15 years; median 22 months) with lymphangioma were treated with OK-432; they received a mean of three injections each. Ten received OK-432 as first line treatment; five were treated after surgery (three had a residual lymphangioma after incomplete removal and two had a late recurrence). OK-432 proved to be effective for primitive as ...
متن کامل[OK-432 therapy for cervicofacial lymphangioma in adults].
The treatment of cervicofacial lymphangiomas has been changing in recent years. OK-432 appears to be a relatively safe and effective treatment option for patients of all ages. An intracystic injection of OK-432 produces a local inflammatory reaction, leading to resolution of the lesion. Cosmetically, the outcome is excellent, leaving no lesions on the skin at the injection site, unlike other sc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Pediatrics and neonatology
دوره 57 3 شماره
صفحات -
تاریخ انتشار 2016